Egypt drug market at EGP 422bn as Cairo practice regroups
Hibridge states on its own site that it is part of Dilogic Group and serves pharmaceutical companies across Egypt, the Gulf and the Levant.
Egypt drug market figures published by the Egyptian Drug Authority on 15 June 2026 put the 2025 market at EGP 422 billion, about US$8.5 billion. Hibridge, a Cairo healthcare consulting firm, states on its own site that it was founded in 2014 and is part of Dilogic Group.
What the regulator published#
The authority put the 2025 market at EGP 422 billion, about US$8.5 billion, which it gave as 37 percent above 2024. It placed Egypt 26th in the world by market size, up from 30th in 2024, and set a stated target of the global top 20 by 2030. The same statement put local production at about 91 percent of the medicines consumed in the country. Products available on the market grew from about 8,500 to more than 10,000. Zawya carried the figures. The authority recorded four billion units by volume and a compound annual growth rate of about 15 percent.
Exports and the 2030 target#
The authority gave pharmaceutical exports as nearly US$1.3 billion at the end of 2025, against a stated target of US$3 billion by 2030, of which US$1.34 billion is set for African markets. The US$3 billion export target is also on record from September 2024, when Egypt Today reported it alongside a figure of 91 in every 100 medicine boxes used in Egypt being made domestically. The Egyptian Gazette reported on 19 August 2026 that the authority retained World Health Organization Maturity Level 3 status for regulating medicines and vaccines, and is working towards Level 4.
What the Cairo firm's site states#
Hibridge gives its founding year as 2014 and its base as Cairo. Its site states that it serves pharmaceutical companies across Egypt, the Gulf and the Levant, and describes itself as part of Dilogic Group and that group's dedicated pharmaceutical practice. The site groups seven services into three headings: meetings and engagement with healthcare professionals, technology, and commercial. The seven are conference and event management, technology integration, business intelligence and analytics, go-to-market and product launch, pharmaceutical marketing, branding and brand strategy, and social media and digital content. Its site is published in English and Arabic.
What the group's site states#
Dilogic Group's site gives 2023 as its founding year and lists a Dubai headquarters with offices in Cairo and London. It sets out six practice areas covering strategy, growth strategy and go-to-market, omnichannel strategy, experience design, marketing operations and operations excellence, applied across seven sector verticals, one of which is healthcare, pharma and life sciences. The site states that headcount is not the metric it optimises for. Crunchbase lists the firm in a band of 11 to 50 employees with a Dubai headquarters. Further company announcements and the Asset Sales Desk carry related filings.
Sources8 sources across 6 domains
- zawya.comZawyaReporting the Egyptian Drug Authority statement of 15 June 2026. Egypt pharmaceutical market EGP 422 billion, about US$8.5 billion, in 2025, up 37 percent on 2024; 26th globally up from 30th in 2024; stated target of the global top 20 by 2030; about 91 percent local production; products from about 8,500 to more than 10,000; four billion units by volume; CAGR about 15 percent; exports nearly US$1.3 billion at end-2025 against a US$3 billion target by 2030 including US$1.34 billion to African markets
- egypttoday.comEgypt TodayPublished 22 September 2024. Egypt pharmaceutical exports target of US$3 billion by 2030 and 91 in every 100 medicine boxes used in Egypt made domestically
- egyptian-gazette.comEgyptian GazettePublished 19 August 2026. Egyptian Drug Authority maintained WHO Maturity Level 3 status for medicines and vaccines and is targeting Level 4
- hibridge.egHibridgeHibridge founded 2014, a Cairo healthcare consulting firm, states it serves pharmaceutical companies across Egypt, the GCC and the Levant and is part of Dilogic Group
- hibridge.egHibridgeHibridge states it is the dedicated pharmaceutical practice of Dilogic Group, and groups seven named services into three headings: meetings and HCP engagement, technology, and commercial
- dilogicgroup.comDilogic GroupDilogic Group founded 2023, Dubai headquarters with offices in Cairo and London, states headcount is not the metric it optimises for
- dilogicgroup.comDilogic GroupDilogic Group lists seven sector verticals including healthcare, pharma and life sciences
- crunchbase.comCrunchbaseCrunchbase lists Dilogic Group in a band of 11 to 50 employees, headquartered in Dubai
Each source above carries the claim it supports. Links open the publisher's own page; their text is not reproduced here beyond what the claim requires, and their rights remain theirs.
Equity Arabia is published by Arabian Media Network. Pieces are produced by the Asset Sales Desk with AI-assisted synthesis of the cited sources and automated verification against the network's editorial policy. Every piece carries a desk rather than a reporter. Corrections are recorded on the piece and on the corrections page.